Clinical trial to test the safety, efficacy of bacteriophage

Cystic fibrosis (CF) is an inherited disorder that causes severe damage to the lungs and other organs in the body.

Related Keywords

San Diego , California , United States , University Of California San Diego , America , Diane Shader Smith , Robert Schooley , Steffanie Strathdee , Mallory Smith , Tom Patterson , Emily Henderson , National Institute Of Allergy , National Institutes Of Health , Cystic Fibrosis Foundation , Mallory Smith Legacy Fund , Antibacterial Resistance Leadership Group , Uc San Diego Health , Mallory Legacy Fund , Department Of Medicine , Uc San Diego School Of Medicine , California San Diego School , Diego School , Diego Health , Innovative Phage Applications , National Institute , Infectious Diseases , National Institutes , Mallory Smith Legacy , Legacy Fund , Shader Smith , Nature Microbiology , Harold Simon Professor , Bacteria , Bacteriophage , Children , Hronic , Clinical Trial , Cystic Fibrosis , Efficacy , Ibrosis , Maging , Lungs , Medicine , Micrograph , Icroscopy , Athogen , Placebo ,